Total Revenue
(in billions)
$92.1
$104.2
$121.9
Total Medical Membership
(in millions)
39.9
41.0
42.9
Net Income Per Diluted Share
(in whole dollars)
$14.19
$18.47
$17.98
Adjusted Net Income Per Diluted Share
(in whole dollars)
$15.89
$19.44
$22.48
Selling, General and Administrative Expense Ratio
15.3%
13.0%
14.4%
Benefit Expense Ratio
84.2%
86.8%
84.6%
Operating Cash Flow
(in billions)
$3.8
$6.1
$10.7
Funding Arrangement
Self-funded 25,296
Fully insured 17,296
Customer Type
Local group 15,614
Medicaid 8,852
National account 7,736
BlueCard® 6,059
Medicare 2,361
FEHB 1,623
Individual 680
| (dollars in millions, except per share data) | 2020 | 2019 | 2018 |
|---|---|---|---|
| Operating Results | |||
| Total operating revenue | $120,808 | $103,141 | $91,341 |
| Total revenue | 121,867 | 104,213 | 92,105 |
| Net income | 4,572 | 4,807 | 3,750 |
| Net Income Per Share | |||
| Basic | $18.23 | $18.81 | $14.53 |
| Diluted | 17.98 | 18.47 | 14.19 |
| Dividends per share | 3.80 | 3.20 | 3.00 |
| Balance Sheet Information | |||
| Total assets | $86,615 | $77,453 | $71,571 |
| Total liabilities | 53,416 | 45,725 | 43,030 |
| Total shareholders’ equity | 33,199 | 31,728 | 28,541 |
| Medical Membership (000’s) | |||
| Commercial and specialty business | 30,089 | 30,022 | 29,814 |
| Government business | 12,836 | 10,978 | 10,124 |
| Total medical membership | 42,925 | 41,000 | 39,938 |
| Customer Type | |||
| Local group | 15,614 | 15,682 | 15,733 |
| Individual | 680 | 684 | 655 |
| National: | |||
| National accounts | 7,736 | 7,596 | 7,588 |
| BlueCard® | 6,059 | 6,060 | 5,838 |
| Total national | 13,795 | 13,656 | 13,426 |
| Medicare | 2,361 | 2,119 | 1,852 |
| Medicaid | 8,852 | 7,265 | 6,716 |
| FEHB | 1,623 | 1,594 | 1,556 |
| Total medical membership | 42,925 | 41,000 | 39,938 |
| Funding Arrangement | |||
| Self-funded | 25,629 | 25,418 | 25,287 |
| Fully insured | 17,296 | 15,582 | 14,651 |
| Total medical membership | 42,925 | 41,000 | 39,938 |
| Other Membership | |||
| Life and disability members | 5,064 | 5,259 | 4,795 |
| Dental members | 6,385 | 6,263 | 5,807 |
| Dental administration members | 1,316 | 5,516 | 5,327 |
| Vision members | 7,536 | 7,261 | 6,946 |
| (in millions, except share data) | December 31, 2020 | December 31, 2019 |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $5,741 | $4,937 |
| Fixed maturity securities, current (amortized cost of $22,222 and $19,021) | 23,433 | 19,676 |
| Equity securities | 1,559 | 1,009 |
| Premium receivables | 5,279 | 5,014 |
| Self-funded receivables | 2,849 | 2,570 |
| Other receivables | 2,830 | 2,807 |
| Other current assets | 4,060 | 3,020 |
| Total current assets | 45,751 | 39,033 |
| Long-term investments: | ||
| Fixed maturity securities (amortized cost of $532 and $487) | 562 | 505 |
| Other invested assets | 4,285 | 4,258 |
| Property and equipment, net | 3,483 | 3,133 |
| Goodwill | 21,691 | 20,500 |
| Other intangible assets | 9,405 | 8,674 |
| Other noncurrent assets | 1,438 | 1,350 |
| Total assets | $86,615 | $77,453 |
| Liabilities and shareholders’ equity | ||
| Liabilities | ||
| Current liabilities: | ||
| Policy liabilities: | ||
| Medical claims payable | $11,359 | $8,842 |
| Other policyholder liabilities | 4,590 | 3,050 |
| Unearned income | 1,259 | 1,017 |
| Accounts payable and accrued expenses | 5,493 | 4,198 |
| Short-term borrowings | — | 700 |
| Current portion of long-term debt | 700 | 1,598 |
| Other current liabilities | 6,052 | 4,127 |
| Total current liabilities | 29,453 | 23,532 |
| Long-term debt, less current portion | 19,335 | 17,787 |
| Reserves for future policy benefits | 794 | 759 |
| Deferred tax liabilities, net | 2,019 | 2,227 |
| Other noncurrent liabilities | 1,815 | 1,420 |
| Total liabilities | $53,416 | $45,725 |
| Commitments and contingencies – Note 14 | ||
| Shareholders’ equity | ||
| Preferred stock, without par value, shares authorized – 100,000,000; shares issued and outstanding – none | — | — |
| Common stock, par value $0.01, shares authorized – 900,000,000; shares issued and outstanding – 245,401,430 and 252,922,161 | 3 | 3 |
| Additional paid-in capital | 9,244 | 9,448 |
| Retained earnings | 23,802 | 22,573 |
| Accumulated other comprehensive income (loss) | 150 | (296) |
| Total shareholders’ equity | 33,199 | 31,728 |
| Total liabilities and shareholders’ equity | $86,615 | $77,453 |
| Years Ended December 31 | |||
| (in millions, except per share data) | 2020 | 2019 | 2018 |
| Revenues | |||
| Premiums | $104,109 | $94,173 | $85,421 |
| Product revenue | 10,384 | 2,760 | — |
| Administrative fees and other revenue | 6,315 | 6,208 | 5,920 |
| Total operating revenue | 120,808 | 103,141 | 91,341 |
| Net investment income | 877 | 1,005 | 970 |
| Net realized gains (losses) on financial instruments | 182 | 67 | (206) |
| Total revenues | 121,867 | 104,213 | 92,105 |
| Expenses | |||
| Benefit expense | 88,045 | 81,786 | 71,895 |
| Cost of products sold | 8,953 | 1,992 | — |
| Selling, general and administrative expense | 17,450 | 13,364 | 14,020 |
| Interest expense | 784 | 746 | 753 |
| Amortization of other intangible assets | 361 | 338 | 358 |
| Loss on extinguishment of debt | 36 | 2 | 11 |
| Total expenses | 115,629 | 98,228 | 87,037 |
| Income before income tax expense | 6,238 | 5,985 | 5,068 |
| Income tax expense | 1,666 | 1,178 | 1,318 |
| Net income | $4,572 | $4,807 | $3,750 |
| Net income per share | |||
| Basic | $18.23 | $18.81 | $14.53 |
| Diluted | $17.98 | $18.47 | $14.19 |
| Dividends per share | $3.80 | $3.20 | $3.00 |
| Years Ended December 31 | |||
| (in millions) | 2020 | 2019 | 2018 |
| Net income | $4,572 | $4,807 | $3,750 |
| Other comprehensive income (loss), net of tax: | |||
| Change in net unrealized gains/losses on investments | 428 | 680 | (418) |
| Change in non-credit component of other-than-temporary impairment losses on investments | — | — | (2) |
| Change in net unrealized gains/losses on cash flow hedges | 12 | (16) | 37 |
| Change in net periodic pension and post-retirement costs | (1) | 26 | (90) |
| Foreign currency translation adjustments | 7 | — | (1) |
| Other comprehensive income (loss) | 446 | 690 | (474) |
| Total comprehensive income | $5,018 | $5,497 | $3,276 |
| Years Ended December 31 | |||
| (in millions) | 2020 | 2019 | 2018 |
| Operating activities | |||
| Net income | $4,572 | $4,807 | $3,750 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Net realized (gains) losses on financial instruments | (182) | (67) | 206 |
| Depreciation and amortization | 1,154 | 1,133 | 1,132 |
| Deferred income taxes | (540) | 81 | 91 |
| Impairment of property and equipment | 198 | — | — |
| Share-based compensation | 283 | 294 | 226 |
| Changes in operating assets and liabilities: | |||
| Receivables, net | (256) | (1,053) | (695) |
| Other invested assets | (32) | (48) | (1) |
| Other assets | (283) | (170) | (26) |
| Policy liabilities | 3,528 | 1,826 | (1,059) |
| Unearned income | 202 | 115 | (36) |
| Accounts payable and other liabilities | 1,978 | (445) | 97 |
| Income taxes | 72 | (325) | 323 |
| Other, net | (6) | (87) | (181) |
| Net cash provided by operating activities | 10,688 | 6,061 | 3,827 |
| Investing activities | |||
| Purchases of investments | (19,492) | (22,954) | (9,671) |
| Proceeds from sales of investments | 11,318 | 18,598 | 9,662 |
| Maturities, calls and redemptions from investments | 4,741 | 2,437 | 1,938 |
| Changes in securities lending collateral | (849) | 254 | (149) |
| Purchases of subsidiaries, net of cash acquired | (1,976) | — | (1,760) |
| Purchases of property and equipment | (1,021) | (1,077) | (1,208) |
| Other, net | (45) | (50) | (71) |
| Net cash used in investing activities | (7,324) | (2,792) | (1,259) |
| Financing activities | |||
| Net repayments of commercial paper borrowings | (150) | (297) | (107) |
| Proceeds from long-term borrowings | 2,484 | 2,473 | 835 |
| Repayments of long-term borrowings | (1,932) | (1,123) | (1,684) |
| Proceeds from short-term borrowings | 970 | 7,590 | 9,120 |
| Repayments of short-term borrowings | (1,670) | (8,035) | (9,250) |
| Changes in securities lending payable | 849 | (254) | 150 |
| Proceeds from issuance of common stock under Equity Units stock purchase contracts | — | — | 1,250 |
| Repurchase and retirement of common stock | (2,700) | (1,701) | (1,685) |
| Cash dividends | (954) | (818) | (776) |
| Proceeds from issuance of common stock under employee stock plans | 176 | 187 | 173 |
| Taxes paid through withholding of common stock under employee stock plans | (128) | (84) | (81) |
| Other, net | 488 | (204) | (186) |
| Net cash used in financing activities | (2,567) | (2,266) | (2,241) |
| Effect of foreign exchange rates on cash and cash equivalents | 7 | — | (2) |
| Change in cash and cash equivalents | 804 | 1,003 | 325 |
| Cash and cash equivalents at beginning of year | 4,937 | 3,934 | 3,609 |
| Cash and cash equivalents at end of year | $5,741 | $4,937 | $3,934 |
| Years Ended December 31 | |||
| 2020 | 2019 | 2018 | |
| Net income per diluted share | $17.98 | $18.47 | $14.19 |
| Add / (Subtract): | |||
| Net realized (gains) losses | (0.72) | (0.26) | 0.78 |
| Amortization of intangibles | 1.42 | 1.30 | 1.36 |
| Loss on extinguishment of debt | 0.14 | 0.01 | 0.04 |
| Business optimization charges | 2.57 | — | — |
| BCBSA litigation settlement | 2.15 | — | — |
| Transaction and integration related costs | 0.19 | 0.04 | 0.03 |
| Litigation expenses | 0.16 | 0.20 | — |
| Tax impact of non GAAP adjustments | (1.42) | (0.32) | (0.51) |
| Rounding impact | 0.01 | — | — |
| Net adjustment items | 4.50 | 0.97 | 1.70 |
| Adjusted net income per diluted share | $22.48 | $19.44 | $15.89 |